1. Wells P, Anderson D. The diagnosis and treatment of venous thromboembolism. Hematology Am Soc Hematol Educ Program. 2013; 2013: 457-63. doi:10.1182/asheducation-2013.1.457 2. Heit JA. Venous thromboembolism epidemiology: implications for prevention and management. Semin Thromb Hemost. 2002 Jun; 28 Suppl 2: 3-13. doi:10.1055/s-2002-32312 3. Deitcher SR, Carman TL. Deep venous thrombosis and pulmonary embolism. Curr Treat Options Cardiovasc Med. 2002 Jun; 4(3): 223-38. 4. Klok FA, Zondag W, van Kralingen KW, van Dijk AP, Tamsma JT, Heyning FH, et al. Patient outcomes after acute pulmonary embolism. A pooled survival analysis of different adverse events. Am J Respir Crit Care Med. 2010 Mar; 181(5): 501-6. doi:10.1164/rccm.200907-1141OC 5. Alpert JS, Smith R, Carlson J, Ockene IS, Dexter L, Dalen JE. Mortality in patients treated for pulmonary embolism. JAMA. 1976 Sep; 236(13): 1477-80. 6. Huerta C, Johansson S, Wallander MA, García Rodríguez LA. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med. 2007 May; 167(9): 935-43. doi:10.1001/archinte.167.9.935 7. Akgüllü Ç, Ömürlü İK, Eryılmaz U, Avcil M, Dağtekin E, Akdeniz M, et al. Predictors of early death in patients with acute pulmonary embolism. Am J Emerg Med. 2015 Feb; 33(2): 214-21. doi:10.1016/j.ajem.2014.11.022 8. Ay C, Simanek R, Vormittag R, Dunkler D, Alguel G, Koder S, et al. High plasma levels of soluble P-selectin are predictive of venous thromboembolism in cancer patients: results from the vienna cancer and thrombosis study (CATS). Blood. 2008 Oct; 112(7): 2703-8. doi:10.1182/blood-2008-02-142422 9. Arram EO, Fathy A, Abdelsamad AA, Elmasry EI. Value of cardiac biomarkers in patients with acute pulmonary embolism. Egypt J Chest Dis Tuberc. 2014; 63(1): 247-52. https://doi.org/10.1016/j.ejcdt.2013.09.016 10. Kleinjan A, Bossuyt P, Cesarman-Maus G, Di Nisio M, Kamphuisen PW, Kramer M, et al. Prediction of venous thromboembolism in cancer patients by tissue factor dependent microparticle coagulant activity, biomarkers and a clinical score. Journal of Thrombosis and Haemostasis. 2013; 11(2): 380-81. 11. Stewart GJ, Ritchie WG, Lynch PR. Venous endothelial damage produced by massive sticking and emigration of leukocytes. Am J Pathol. 1974 Mar; 74(3): 507-32. 12. von Brühl ML, Stark K, Steinhart A, Chandraratne S, Konrad I, Lorenz M, et al. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012 Apr; 209(4): 819-35. doi:10.1084/jem.20112322 13. Kayrak M, Erdoğan HI, Solak Y, Akilli H, Gül EE, Yildirim O, et al. Prognostic value of neutrophil to lymphocyte ratio in patients with acute pulmonary embolism: a restrospective study. Heart Lung Circ. 2014 Jan; 23(1): 56-62. doi:10.1016/j.hlc.2013.06.004 14. Kundi H, Balun A, Cicekcioglu H, Cetin M, Kiziltunc E, Cetin ZG, et al. The relation between platelet-to-lymphocyte ratio and pulmonary embolism severity index in acute pulmonary embolism. Heart Lung. 2015 Jul-Aug; 44(4): 340-3. doi:10.1016/j.hrtlng.2015.04.007 15. Fan X, Huang B, Lu H, Zhao Z, Lu Z, Yang Y, et al. Impact of admission white blood cell count on short- and long-term mortality in patients with type A acute aortic dissection: An observational study. Medicine (Baltimore). 2015 Oct; 94(42): e1761. doi:10.1097/MD.0000000000001761 16. Núñez J, Fácila L, Llàcer A, Sanchís J, Bodí V, Bertomeu V, et al. [Prognostic value of white blood cell count in acute myocardial infarction: long-term mortality]. Rev Esp Cardiol. 2005 Jun; 58(6): 631-9. [Article in Spanish] 17. Núñez J, Núñez E, Bodí V, Sanchis J, Miñana G, Mainar L, et al. Usefulness of the neutrophil to lymphocyte ratio in predicting long-term mortality in ST segment elevation myocardial infarction. Am J Cardiol. 2008 Mar; 101(6): 747-52. doi:10.1016/j.amjcard.2007.11.004 18. Azab B, Zaher M, Weiserbs KF, Torbey E, Lacossiere K, Gaddam S, et al. Usefulness of neutrophil to lymphocyte ratio in predicting short- and long-term mortality after non-ST-elevation myocardial infarction. Am J Cardiol. 2010 Aug; 106(4): 470-6. doi:10.1016/j.amjcard.2010.03.062 19. Papa A, Emdin M, Passino C, Michelassi C, Battaglia D, Cocci F. Predictive value of elevated neutrophil-lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease. Clin Chim Acta. 2008 Sep; 395(1-2): 27-31. doi:10.1016/j.cca.2008.04.019 20. Shah N, Parikh V, Patel N, Patel N, Badheka A, Deshmukh A, et al. Neutrophil lymphocyte ratio significantly improves the Framingham risk score in prediction of coronary heart disease mortality: insights from the National Health and Nutrition Examination Survey-III. Int J Cardiol. 2014 Feb; 171(3): 390-7. doi:10.1016/j.ijcard.2013.12.019 21. Erturk M, Cakmak HA, Surgit O, Celik O, Aksu HU, Akgul O, et al. Predictive value of elevated neutrophil to lymphocyte ratio for long-term cardiovascular mortality in peripheral arterial occlusive disease. J Cardiol. 2014 Nov; 64(5): 371-6. doi:10.1016/j.jjcc.2014.02.019 22. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013 Oct; 88(1): 218-30. doi:10.1016/j.critrevonc.2013.03.010 23. Akpek M, Kaya MG, Lam YY, Sahin O, Elcik D, Celik T, et al. Relation of neutrophil/lymphocyte ratio to coronary flow to in-hospital major adverse cardiac events in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol. 2012 Sep; 110(5): 621-7. doi:10.1016/j.amjcard.2012.04.041 24. Hirano Y, Aziz M, Wang P. Role of reverse transendothelial migration of neutrophils in inflammation. Biol Chem. 2016 Jun; 397(6): 497-506. doi:10.1515/hsz-2015-0309 25. Cheng OZ, Palaniyar N. NET balancing: a problem in inflammatory lung diseases. Front Immunol. 2013 Jan; 4: 1. doi:10.3389/fimmu.2013.00001 26. Karataş MB, İpek G, Onuk T, Güngör B, Durmuş G, Çanga Y, et al. Assessment of prognostic value of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in patients with pulmonary embolism. Acta Cardiol Sin. 2016 May; 32(3): 313-20. 27. Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. 2012 Jan; 122(1): 327-36. doi:10.1172/JCI57990 28. Özpelit E, Akdeniz B, Özpelit ME, Tas S, Bozkurt S, Tertemiz KC, et al. Prognostic value of neutrophil-to-lymphocyte ratio in pulmonary arterial hypertension. J Int Med Res. 2015 Oct; 43(5): 661-71. doi:10.1177/0300060515589394
|